AngioDynamics, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BB5621
ANGO
AngioDynamics, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Instruments & Supplies
NAME
AngioDynamics, Inc.
ISIN
US03475V1017
TICKER
ANGO
MIC
XNAS
REUTERS
ANGO.OQ
BLOOMBERG
ANGO US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Wed, 08.01.2025
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the second quarter of fiscal year 2025, which ended November 30, 202...
AngioDynamics
Mon, 06.01.2025
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive...
AngioDynamics
Mon, 06.01.2025
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that the Company will host a virtual investor event on Wednesday, January 8, 2025 at 9:30a...
AngioDynamics
Thu, 19.12.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the second quarter of fiscal year 2025 before the mark...
AngioDynamics
Mon, 09.12.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System fo...
AngioDynamics
Wed, 23.10.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the launch of an international multi-center prospective registry study to assess the long term e...
AngioDynamics
Mon, 21.10.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that IRE has received CPT® Category I codes for the treatment of lesions in the prostate and liv...
AngioDynamics
Thu, 03.10.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2025, which ended August 31, 2024.
...
AngioDynamics
Thu, 19.09.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the launch of the Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Effi...
AngioDynamics
Thu, 19.09.2024
AngioDynamics
US03475V1017
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the first quarter of fiscal year 2025 before the marke...
AngioDynamics
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
